Press Releases

 
Press Releases
Date Title and Summary View
May 31, 2017 JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7, 2017 at 3:00 p.m. Eastern Time at the Gran...
May 22, 2017 Initial MosaiQ manufacturing system commissioned and validatedFirst "commercially ready" MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expected in 3QCY17...
May 9, 2017 JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the UBS Global Healthcare Conference on Tuesday, May 23, 2017 at 10:30 a.m. Eastern Time at the Grand Hyatt New ...
May 9, 2017 JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and fiscal year ended March 31, 2017 will be released after market close on Monday, May 22, 2017.Quotient ...
Apr 10, 2017 JERSEY, Channel Islands, April 10, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering of 8,050,000 of its ordinary shares at a price to the public of $6.00 per share, which includes the exercise in full by the underwr...
Apr 5, 2017 JERSEY, Channel Islands, April 05, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 7,000,000 of its ordinary shares at a price to the public of $6.00 per share. The net proceeds to Quotient from this offering are...
Apr 4, 2017 JERSEY, Channel Islands, April 04, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of its ordinary shares. Jefferies LLC is acting as sole book-running manager and BTIG, LLC is a...
Mar 30, 2017 Antibody Detection — enhanced detection versus predicate technologiesManufacturing of Microarrays for European field trials planned to commence in early AprilMosaiQ™ instrument development completed and formal validation has commence...
Mar 23, 2017 Products are rare antisera blood typing reagents developed and manufactured by QuotientU.S. commercialization of these products will extend the range and method of reagents available in the market for antigen phenotypingEquivalent products are already...
Feb 22, 2017 JERSEY, Channel Islands, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 10:40 a.m. E...
Page:
1
... NextLast
= add release to Briefcase